Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
06/2002
06/19/2002EP1214303A1 Heterocyclic compounds and methods of use thereof
06/19/2002EP1214301A1 Hypoglycemic n,n-arylsulfonylglycine compounds
06/19/2002EP1214292A1 Tyrosine derivatives
06/19/2002CN1354742A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a
06/19/2002CN1086430C Method of optically brightening polyamides
06/18/2002US6407285 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
06/18/2002US6407127 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046173A1 Fused heteroaromatic glucokinase activators
06/13/2002WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002WO2002046129A2 Inhibitors of histone deacetylase
06/13/2002WO2002018353A3 Oxazolidinone chemotherapeutic agents
06/13/2002WO2001098297A3 A thiazine oxazolidinone
06/13/2002WO2001083438A3 New gamma selective retinoids
06/13/2002US20020072621 Method for producing epoxide crystal
06/13/2002US20020072613 Process for producing acetophenone compound
06/13/2002US20020072528 Are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit T-helper-type 2 immune response; useful for therapy of viral and neoplastic diseases
06/13/2002DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof
06/13/2002CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide
06/12/2002EP1213285A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors
06/12/2002EP1213284A1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
06/12/2002EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors
06/12/2002EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
06/12/2002EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/12/2002EP0782577B1 Asymmetric ligands useful for transition metal catalyzed bond forming reactions and epoxide reactions therewith
06/12/2002EP0751939B1 Naphthylamides as central nervous system agents
06/12/2002CN1353718A Novel ligands for chiral catalysis
06/12/2002CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof
06/11/2002US6403957 Nucleic acid reading and analysis system
06/11/2002US6403804 Allowing hydrazine to react on optically active acid ester having hydroxyl group at 3-position to give optically active hydrazide having hydroxyl group at 3-position, subjecting optically active hydrazide to curtius rearrangement
06/11/2002US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
06/11/2002US6403656 Skin disorders
06/11/2002US6403320 Support bound probes and methods of analysis using the same
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors
06/06/2002WO2002044144A2 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
06/06/2002WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
06/06/2002WO2002043716A2 Method for regulating prostate gland volume with insulin sensitizers
06/06/2002WO2002014294A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
06/06/2002US20020068833 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via Ritter reaction
06/05/2002EP1210345A1 Oxazole ppar antagonists
06/05/2002EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
06/05/2002EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
06/05/2002EP1210324A1 Substituted cyclopentenes, their preparation and their use for chiral scaffolds
06/04/2002US6399783 Chemical intermediate for taxol
06/04/2002US6399773 Autoimmune disease; transplanting organs
06/04/2002US6399640 Arylthiazolidinedione and aryloxazolidinedione derivatives
06/04/2002CA2094810C Process for preparing florfenicol, its analogs and oxazoline intermediates thereto
06/04/2002CA2046139C Bis-oxazolidines, oxazolidine mixtures consisting essentially thereof, a process for their production and their use as hardeners for plastics precursors containing isocyanate groups
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002014275A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/30/2002WO2001085149A3 Felbamate derived compounds
05/30/2002US20020065280 Oxazolidinones to treat eye infections
05/30/2002US20020065274 Methods of using novel compounds as neuro-protective agents
05/30/2002US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis
05/30/2002US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/29/2002EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP0786457B1 Azole derivatives
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents
05/28/2002US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease
05/28/2002US6395491 Coding and storing information on substrate; code biopolymer sequence, attach to substrate, recover information by replication of biopolymer sequence
05/28/2002US6395282 Carrier molecule conjugated to specific autoinducers; vaccines for the treatment and prevention of infection
05/23/2002WO2002040445A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002040444A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002040020A1 Novel use of certain insulin sensitizers or ppar-gamma agonists
05/23/2002WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide
05/23/2002US20020062027 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
05/23/2002US20020062004 Enantioselective hydrogenation
05/23/2002US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators
05/23/2002US20020061912 Piperidinylmethyloxazolidinone derivative
05/22/2002EP1207152A2 Pesticides
05/22/2002EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
05/22/2002EP1206457A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
05/22/2002EP1206187A2 High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof
05/22/2002EP0766676B1 Compounds for inhibiting phosphodiesterase iv
05/22/2002EP0712395B1 Process for the preparation of fluoroalkenylthio heterocyclic derivatives
05/22/2002EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
05/22/2002CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
05/21/2002US6392067 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
05/21/2002US6392055 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A
05/21/2002US6392046 Aids therapy
05/21/2002US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer
05/16/2002WO2002038532A1 Optically active amine derivative and method of synthesis
05/16/2002WO2002038120A1 Photo-labile pro-fragrance conjugates
05/16/2002WO2002023784A3 Cysteine protease inhibitors
05/16/2002US20020058819 Reacting hydroxycarboxylate, urea and a metal alkoxide in aromatic hydrocarbon to produce metal salt of 2,4-oxazolidinedione compound
05/16/2002US20020058810 As antiinflammatory agents
05/16/2002US20020058666 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands
05/16/2002DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/15/2002CN1349519A Glucokinase activators
05/15/2002CN1349515A Benzoazole compounds, process for the preparation thereof and herbicides
05/15/2002CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone
05/15/2002CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents
05/15/2002CN1349411A Compositions containing benzimidazolones and progestogens
05/14/2002US6387941 Antiserotonine agents
05/14/2002US6387940 Heterocyclylmethyl-substituted pyrazole derivatives